Pure Harvest Corporate Group, Inc. Share Price Other OTC
Equities
PHCG
US74625M1018
Pharmaceuticals
Sales 2019 | 0.04 3.2 | Sales 2020 | 0.74 61.15 | Capitalization | 31.42M 2.61B |
---|---|---|---|---|---|
Net income 2019 | -1M -83.12M | Net income 2020 | -6M -499M | EV / Sales 2019 | 43,08,96,057 x |
Net cash position 2019 | 457K 37.96M | Net Debt 2020 | 2.87M 238M | EV / Sales 2020 | 4,66,05,076 x |
P/E ratio 2019 |
-15.5
x | P/E ratio 2020 |
-3.88
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 62.22% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 02/15/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Gregarek
CEO | Chief Executive Officer | 44 | 02/15/02 |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |